- Home
- ABEO vs FLYX Comparison
ABEO vs FLYX Comparison
Compare ABEO & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- FLYX
- Stock Information
- Founded
- ABEO N/A
- FLYX 2015
- Country
- ABEO United States
- FLYX United States
- Employees
- ABEO N/A
- FLYX N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- FLYX Blank Checks
- Sector
- ABEO Health Care
- FLYX Finance
- Exchange
- ABEO Nasdaq
- FLYX Nasdaq
- Market Cap
- ABEO 237.4M
- FLYX 264.1M
- IPO Year
- ABEO 1980
- FLYX N/A
- Fundamental
- Price
- ABEO $4.92
- FLYX $3.08
- Analyst Decision
- ABEO Strong Buy
- FLYX
- Analyst Count
- ABEO 5
- FLYX 0
- Target Price
- ABEO $17.00
- FLYX N/A
- AVG Volume (30 Days)
- ABEO 834.1K
- FLYX 8.9K
- Earning Date
- ABEO 05-14-2025
- FLYX 01-01-0001
- Dividend Yield
- ABEO N/A
- FLYX N/A
- EPS Growth
- ABEO N/A
- FLYX N/A
- EPS
- ABEO N/A
- FLYX N/A
- Revenue
- ABEO N/A
- FLYX $327,274,000.00
- Revenue This Year
- ABEO N/A
- FLYX $35.08
- Revenue Next Year
- ABEO $539.93
- FLYX N/A
- P/E Ratio
- ABEO N/A
- FLYX N/A
- Revenue Growth
- ABEO N/A
- FLYX 3.78
- 52 Week Low
- ABEO $3.05
- FLYX $1.79
- 52 Week High
- ABEO $8.45
- FLYX $8.39
- Technical
- Relative Strength Index (RSI)
- ABEO 51.29
- FLYX 49.14
- Support Level
- ABEO $3.93
- FLYX $2.95
- Resistance Level
- ABEO $5.02
- FLYX $3.19
- Average True Range (ATR)
- ABEO 0.41
- FLYX 0.19
- MACD
- ABEO 0.06
- FLYX 0.00
- Stochastic Oscillator
- ABEO 90.83
- FLYX 53.79
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 90 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.